Protease Cleavage Reporter Assay for GPCR Interaction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional G-protein based signal transduction assays for GPCRs are challenging due to the need for knowing G-protein specificity and are prone to false results from endogenous GPCRs and signaling factors, making it difficult to accurately monitor ligand/GPCR interactions.
Innovation Solution
A method involving transformed or transfected cells with specific nucleic acid molecules encoding test proteins and a protease cleavage site, along with a reporter gene activator, to determine if a test compound modulates protein/protein interactions by measuring reporter gene activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional G-protein based signal transduction assays are used to monitor ligand/GPCR interactions, then receptor activity can be measured through effector pathway output, but the assay requires knowledge of G-protein specificity and is prone to false results from endogenous GPCRs and signaling factors
Solution Approach 1:
The invention extracts the measurement function from the complex G-protein signaling pathway and relocates it to a simplified reporter gene system. The GPCR is fused to a reporter gene (e.g., luciferase, GFP) under the control of a constitutive promoter, allowing direct visualization of receptor localization and interaction without requiring G-protein coupling or effector pathway activation. This extraction eliminates the need for knowledge of G-protein specificity and reduces interference from endogenous signaling factors.
Solution Approach 2:
The invention introduces a protease cleavage site as an intermediary element between the GPCR and the reporter gene. When a ligand binds to the GPCR, it triggers a conformational change that activates an associated protease to cleave the fusion protein at the cleavage site, releasing the reporter gene product. This intermediary mechanism translates the ligand-receptor interaction into a measurable signal without requiring complex G-protein signaling pathways.
2Adaptability or versatility
If conventional G-protein based assays are used, then receptor activity can be monitored through cAMP accumulation or calcium release, but the assay is difficult to develop for targets with unknown G-protein coupling and requires engineering to force coupling to specific pathways
Solution Approach 1:
The invention creates a universal assay platform that can be applied to any GPCR regardless of its native G-protein coupling. By fusing the GPCR directly to a reporter gene or protease cleavage site, the system achieves multi-functionality: it can monitor ligand binding, receptor activation, and protein-protein interactions for any GPCR target without requiring target-specific engineering of G-protein coupling pathways.
Solution Approach 2:
Instead of engineering the GPCR to couple to a specific G-protein pathway (conventional approach), the invention inverts the strategy by making the GPCR itself the reporter. The receptor fusion protein directly reports its activation state through changes in localization, fluorescence, or proteolytic cleavage, eliminating the need to force coupling to engineered effector pathways.
3Reliability
If conventional G-protein based assays are used, then effector pathway output can be measured, but endogenous GPCRs and signaling factors may modulate the measured pathways leading to false results
Solution Approach 1:
The invention applies local quality by creating a localized, controlled environment for the GPCR-reporter fusion protein. The fusion construct is designed with specific properties (constitutive promoter, defined fusion partner, specific cleavage site) that ensure the measured signal originates solely from the engineered GPCR-reporter interaction, not from endogenous GPCRs or signaling factors. This localized control enhances reliability by isolating the measurement from harmful environmental interference.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for a simpler and more accurate assessment of protein/protein interaction modulation without requiring knowledge of G-protein pathways, reducing false results and enhancing the specificity of ligand/GPCR interaction analysis.
Implementation Method 1
a nucleotide sequence encoding a cleavage site for a protease or a portion of a protease, and (b) a nucleotide sequence which encodes a protease or a portion of a protease
Data Source
AI summary
The invention relates to a method for determining if a test compound, or a mix of compounds, modulates the interaction between two proteins of interest. The determination is made possible via the use of two recombinant molecules, one of which contains the first protein a cleavage site for a proteolytic molecules, and an activator of a gene. The second recombinant molecule includes the second protein and the proteolytic molecule. If the test compound binds to the first protein, a reaction is initiated whereby the activator is cleaved, and activates a reporter gene.